Genovate Biotechnology Co., Ltd. (GENOVATE BIOTECHNOLOGY CO. LTD.) aksje
4130.TWO
Stengt$26.30-0.05 (-0.19%)
Laster graf...
GENOVATE BIOTECHNOLOGY CO. LTD.
Market Cap
$3,596,524,800
Åpning26.40
Høy26.40
Lav25.95
Volum93.96k
P/E263.00
Markedsverdi3.6B
52-ukers høy38.89
52-ukers lav17.65
Gj.sn. volum1.07M
Utbytte0.37%
BetaN/A
EPS0.10
Om Genovate Biotechnology Co., Ltd. (GENOVATE BIOTECHNOLOGY CO. LTD.) aksje
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.
Selskapsinformasjon
Børs: Taipei Exchange (TWO)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
No. 1, Gongye 1st Road
30351 Hsinchu City, Taiwan
30351 Hsinchu City, Taiwan
Telefon: + 886 3 598 2221
Nettside: https://www.genovate-bio.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål